التفاصيل البيبلوغرافية
| العنوان: |
The Minimally Invasive Treatment of Visceral Artery Pseudoaneurysms: A Retrospective Observational Single Centre Cohort Study on Glue Embolization. |
| المؤلفون: |
Borghese, Ottavia1,2 ottaviaborghese@gmail.com, Ganimede, Maria Porzia3, Briatico Vangosa, Alessandra3, Pisani, Angelo4, Vidali, Sofia5, Di Stasi, Carmine3, Burdi, Nicola3, Semeraro, Vittorio3 |
| المصدر: |
Vascular & Endovascular Surgery. Nov2021, Vol. 55 Issue 8, p831-837. 7p. |
| مصطلحات موضوعية: |
*PATIENT aftercare, *SCIENTIFIC observation, *BLOOD vessels, *ENDOSCOPIC surgery, *VEGETABLE oils, *CONVALESCENCE, *MESENTERIC artery, *THERAPEUTIC embolization, *RETROSPECTIVE studies, *TREATMENT effectiveness, *DISEASE relapse, *FALSE aneurysms, *HOSPITAL wards, *DESCRIPTIVE statistics, *COMPUTED tomography, *ADHESIVES, *LONGITUDINAL method |
| مصطلحات جغرافية: |
ITALY |
| مستخلص: |
Objective: The objective is to report a single centre experience in the embolization of visceral artery pseudoaneurysms with N-butyl-cyanoacrylate-methacryloxy sulfolane (NBCA-MS). Methods: A retrospective observational cohort study was conducted on data about all consecutive patients treated for visceral artery pseudoaneurysms in the Interventional Radiology Unit of SS Annunziata Hospital, in Taranto (Italy) between January 2016 and July 2020. Only patients treated with NBCA-MS embolization were included. Clinical and technical outcomes were evaluated during in-hospital stay and at 3-month follow-up by computed angiotomography (CTA). Results: Among 89 patients undergoing treatment for visceral artery pseudoaneurysm, a total of 58 (65.2%) patients (n = 32, 55.2% men; median age 45.8 years, range: 35–81) treated with NBCA-MS only were enrolled. Pseudoaneurysms were located in the renal artery (n = 18 cases, 31%), in the splenic artery (n = 27, 46.6%), in the intra-parenchymal hepatic artery (n = 3, 5.2%), in the common hepatic artery (n = 4, 6.9%) or in the pancreatic artery (n = 6, 10.3%). N-butyl-cyanoacrylate was diluted 1:1 with Lipiodol ultra-fluid, and mean volume injected was 0.6 ± 0.3 mL (range: 0.2–2.8 mL). Embolization was technically and clinically successful in all patients (n = 58, 100%) with an immediate total thrombosis of the pseudoaneurysm at the completion angiography. No systemic complications were noted in all cases. Five cases (8.6%) of non-target vessel embolization occurred without any clinical complication. No pseudoaneurysm recurrence was detected at the CTA control 1 day postoperatively. In one case (1.7%), a recurrence was detected 4 days after the initial treatment and successfully managed by a repeated NBCA-MS embolization. During the hospital stay, 56 patients recovered well but 2 (3.4%) died from multi-organ failure not related to the embolization. No recurrences were detected at the 3-month postoperative CTA in the remaining patients. Conclusions: In properly selected patients affected with visceral artery pseudoaneurysms, NBCA-MS represents a definitive and safe embolization agent. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
